Vertical SaaS
Investment Thesis
This basket targets the Vertical SaaS theme, which delivers industry-specific cloud software platforms that embed deeply into specialized workflows, delivering higher retention, pricing power, and ROI than horizontal alternatives. The 20-name portfolio spans sectors including life sciences, restaurants, and other targeted verticals, with equal 5.2% allocations to top holdings Veeva Systems (VEEV), Toast (TOST), and Olo (OLO), each carrying an exposure score of 68. The investment logic rests on structural tailwinds: the vertical SaaS market reached approximately $143 billion in 2026 and is projected to grow at a 16.3% CAGR through 2035, outpacing the broader SaaS market as domain expertise, proprietary datasets, and embedded AI enable mission-critical solutions that displace legacy systems and drive outsized outcomes—vertical players are up to 3.3 times more likely to become financial outliers.
Key risks include sector-specific cyclical exposure, such as restaurant traffic and consumer spending pressures affecting restaurant-focused names, alongside broader SaaS dynamics like potential AI-driven internal tool-building that could pressure churn or pricing in less entrenched workflows. The highest-conviction position is Veeva Systems, the dominant cloud provider for life sciences with leading solutions in CRM, regulatory, clinical, and quality management across a highly regulated, data-intensive industry; its sticky platform serves top pharmaceutical and biotech firms, commands premium economics with consistent high-20s net margins, and maintains a wide moat through compliance depth and workflow integration that competitors struggle to replicate.
Theme Overview
Geographic focus: US, Global
Holdings
| Ticker | Company | Weight |
|---|---|---|
| VEEV | VEEV | 5.2% |
| TOST | TOST | 5.2% |
| OLO | OLO | 5.2% |
| PCOR | PCOR | 5.2% |
| NCNO | NCNO | 5.2% |
| GWRE | GWRE | 5.2% |
| AGYS | AGYS | 5.1% |
| MLNK | MLNK | 5.1% |
| APPF | APPF | 5.1% |
| ALKT | ALKT | 5.0% |
| TTAN | TTAN | 5.0% |
| PAR | PAR | 4.9% |
| DOCS | DOCS | 4.9% |
| LZ | LZ | 4.8% |
| QTWO | QTWO | 4.8% |
| JKHY | JKHY | 4.8% |
| HCAT | HCAT | 4.8% |
| HSTM | HSTM | 4.8% |
| CPSI | CPSI | 4.8% |
| BLND | BLND | 4.8% |
Portfolio Analytics
Get research notes before the opening bell
This report was generated by XVARY automated research pipelines. Not investment advice. Data sourced from third-party providers and may contain inaccuracies. Disclaimer · Privacy · Terms